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Longitudinal tracking and accumulation of polymeric nanoparticles in the context 
of cancer has largely occurred through identification of a fluorescent cargo.  In this study, 
we created a dual extracellular acidic pH targeted polypyrrole-based hollow nanoparticle 
as a theranostic (maintain both therapeutic and diagnostic capabilities) agent for improved 
detection and treatment of ovarian cancer.  Polypyrrole-hollow nanospheres (PPy-CS) 
were fabricated through the removal of a silver chloride (AgCl) core, which served as a 
template, followed by coating with chitosan and further tumor targeted with a pH low 
insertion peptide, V7. We exploited the NIR-absorbing property of polypyrrole to track both 
the nanoparticle separately from its NIR-fluorescent cargo. Utilizing the absorbing 
properties of the PPy-CS which contained an IR-780 cargo, multispectral optoacoustic 
tracking of phantom-based models revealed that both polypyrrole and IR-780 were 
separately identified indicating both the presence of the nanomaterial and cargo dye.   
SUMMARY: 
In this study, a nanoparticle was developed to serve as means to enhance the 
detection of ovarian cancer tumor cells in vitro.  A unique feature of this nanoparticle was 
its ability to actively target the acidic microenvironment found in the extracellular matrix of 
all tumor cells. The nanoparticle was synthesized by utilizing a polymer-base and then 
encapsulated with chitosan and the modified targeting peptide.  A series of 
characterization studies and assays were conducted to determine the effectiveness of the 
nanoparticle.  Characterization studies demonstrated the nanoparticle displayed an 
appropriate size of approximately 50 nm.  This size is small enough to not be detected by 
macrophage in the liver and large enough not to be effluxed out of the vasculature of the 
tumor microenvironment.  Assays demonstrated the nanoparticle’s ability to maintain its 
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cargo and actively target tumor environments with minimal off-targeting.  The nanoparticle 
was placed in an optoacoustic tomographic imaging system to determine its ability to be 
tracked by the imaging system.  The nanoparticle displayed signaling within the imaging 
system both with the infrared dye and alone.   
1.  INTRODUCTION  
In the United States, ovarian cancer is the fifth leading cause of cancer-related 
deaths among women.  Although only affecting approximately 1 out every 75 women, the 
5-year survival rate is only approximately 17%.  The reason for this rather low survival rate 
is due to the lack of earlier detection of ovarian cancer.  Most women who are diagnosed 
with ovarian cancer are being diagnosed in later stages (III and IV) rather than the earlier 
stages (I and II), where treatment is much more beneficial and effective.  The current 
imaging modalities utilized are those such as magnetic resonance imaging (MRI), 
computed tomography (CT), and positron emission tomography (PET).  The lack of earlier 
detection stems from the inability for most imaging modalities to differentiate the presence 
of early stage ovarian tumors.  
The current method of treatment consists of rounds of chemotherapy focused 
around the Enhanced Permeability Retention (EPR) effect.  The EPR effect is the 
phenomenon in which molecules of certain molecules circulate through the body and 
eventually accumulate in tumor tissues much more so than in non-malignant areas.  
However, there are limitations to the effectiveness of this method of treatment.  Most 
chemotherapeutics are highly cytotoxic, compounds harmful to living cells, and display 
harmful effects to non-malignant areas.  Due to the problems current methods have faced, 
alternative treatment options have been developed to provide patients with better care.   
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The use of nanovehicles, targeting nanoparticles containing specified cargo, as a 
possible contrasting agent has shown great promise in substantially improving the 
detection and treatment of cancer [1, 2].  However, there still remain underlying problems 
and limitations to their effectiveness.  The development of novel metallic-based 
nanovehicles utilizing receptor-targeting mechanisms has been extensively studied, due 
in part to the ability to track these metallic nanoparticles by means of nuclear imaging 
modalities and more recently optoacoustic imaging [3].  Unfortunately, the majority of 
metal components (Fe, Zn, Cu, Ti, Co, etc.) found in these nanoparticles exhibit some 
level of cytotoxicity.   More specifically, the nanosized particles of these metal-oxides have 
recently shown to be toxic to some organisms [4].  Therefore, the use of polymer-based 
nanoparticles has garnered much attention as a possible theranostic tool in the treatment 
of cancer [5].  This interest is due to the low-cytotoxicity, controllable permeability, and 
surface functionality inherently found in polymer-based hollow nanospheres [6-8].  
However, polymer-based nanoparticles themselves have encountered obstacles 
which have resulted in its further development as well.  Difficulties in tracking polymer-
based nanoparticles result from a general requirement of additional contrast dyes, radio-
labels, or other tracking moieties to determine in vivo biodistribution and 
accumulation.  With this in mind, a traceable compound, pyrrole, was selected to provide 
an encapsulation coat for cargo.   Uniquely, polypyrrole polymers display an inherent 
absorbing property in which the pyrrole absorbs at the higher level of the spectrum, 
approximately 980 nm [9].  This inherent emittance of signal, by the pyrrole nanoparticle, 
allows for enhanced levels of tracking of the nanocontrasting agent, while in vivo with the 
use of optoacoustic tomography.  Nanocontrasting agents serve as vehicles which contain 
contrast agents, such as dyes, that allow for better detection by an imaging modality.  This 
polypyrrole chitosan-coated hollow nanosphere (PPy-CS Hollow Nanosphere) is unique 
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in the fact that it emits a photoacoustic signal without the aid of an additional NIR-dye 
cargo.  From the research we have conducted, contemporary nanoparticles do not display 
any detectable absorbance properties which would allow for such enhanced 
detection.  This nanoparticle, in unison with the emerging modality of optoacoustic 
imaging, can address many of the shortcomings of current diagnosis methods as well as 
enhance targeted drug delivery to tumor cells.             
  Currently, nuclear imaging is the foremost imaging modality used in terms of non-
invasive in-situ imaging of biological tissues and materials.  However, with the need for 
further improvement of image resolution and quality, optoacoustic imaging has emerged 
as a promising novel biomedical imaging modality [10, 11].  Unlike nuclear imaging, 
optoacoustic imaging does not solely utilize radio-labels and radioactive material [12] as 
a means to trace a contrasting agent, rather it emits light energy which then reflects off of 
the contrast agent and produces a sound wave which is then recorded by an ultrasonic 
transducer allowing for an ultrasound image with higher resolution [13-16].   
Multispectral optoacoustic tomography (MSOT) combines the benefits of 
enhanced sensitivity found in optical imaging and the depth of detection that is usually 
associated with ultrasound [17].  The ability for detection without the need for application 
of radiation is a significant benefit due to the damaging side-effects associated with 
prolonged exposure to radiation [18, 19].   An advantage of MSOT imaging also includes 
its ability to compile molecular and functional information, with high spatial resolution, in 
real-time.  Also, it is able to distinguish various contrasting agents already present within 
the tissue, e.g. hemoglobin [16, 18].  Due to optoacoustic imaging’s ability to detect 
absorbing molecules at depth, it provides a means of detection for absorbing nanoparticles 
which would allow for determination of the overall accumulation and biodistribution in real 
time.  In current mice models, this process occurs over a process of hours until the 
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nanoparticles are able to completely reach the tumor microenvironment.  The advantages 
of optoacoustic imaging capabilities provide essential features including less exposure to 
radiation, rendering of more in-depth imaging, and a lesser invasive procedure than that 
of current modalities. Therein lies the need for the further development of enhanced tumor 
targeting agents [20-24].    
In order for nanovehicles to be effective in the clinic, the nanovehicle must have: 
1) increased tumor-specific accumulation and reduced off-target binding, and 2) increased 
signal/payload within tumors than compared to current diagnostic or therapeutic 
agents   While additional biological barriers, e.g. poor vascularity [25] and presence of 
stroma [26], associated with recalcitrant tumors present additional challenges for 
development of nanovehicles, these recalcitrant tumors also offer the potential for high 
clinical impact for theranostic agents. Tumor-environments display various hallmark 
features which include acidic extracellular pH [27], increased levels of hypoxia [28], 
presence of autoantibodies [29] etc.  With this in mind, we exploited the presence of acidic 
pH in the extracellular matrix of tumor cells as a general feature that would not be present 
in non-malignant tissue.  In the clinic, tumors have acidic pHe (6.4–6.8) compared to non-
malignant tissue (pHe 7.2-7.4) [30]; however, this small difference in extracellular pH alters 
the function, metastatic potential, and survival of tumor cells.  To exploit the acidic 
extracellular pH as a targeting strategy for our polypyrrole nanocontrasting agent, we 
utilized a V7 pHLIP (pH Low Insertion Peptide), which changes conformation in response 
to its environment.  In neutral pHe (7.2-7.4), it maintains a globular form and transforms to 
a transmembrane alpha-helix at acidic pHe conditions (6.4-6.8), this then allows the 
conjugated particle to insert and anchor into tumor cells [31-33].   
pHLIPs are a specialized group of peptides derived from the bacteriorhodopsin C 
helix which maintain water solubility and semi-hydrophobicity.  In neutral or higher pH 
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levels, the pHLIP is monomeric, remains non-reactive, and retains an unstructured or 
globular form.  However, when placed in an acidic environment, it leads to the protonation 
of negatively charged residues on the helical segment and results in a shift in equilibrium, 
ultimately forming the alpha-helix structure [31].  Multiple studies have been successfully 
conducted with the use of pHLIPS as an additional modifier to existing polymer-based 
nanoparticles for pH-sensitive in vivo targeting for delivery as well as imaging [34, 35].    
Recently, several types of ligand based probes and inorganic nanoparticles have 
been detected using optoacoustic imaging for improved cancer detection in glioma, breast, 
and pancreatic cancers [36].  Near-infrared(NIR) fluorescent dyes conjugated to tumor 
targeted ligands and gold nanomaterials (including nanorods, and gold composite 
nanostructures) are likely the most-widely explored exogenous contrast agents for 
optoacoustic imaging.  A number of other inorganic nanomaterials, including gold and 
silver nanoparticles, have also demonstrated tumor specificity [6, 37], albeit often in 
subcutaneous tumors.  However, the majority of inorganic nanoparticles have high uptake 
in the MPS system and may remain in the subject for long periods of time without the 
potential of degradation.  This is a serious problem for the development of nanocontrasting 
agents for clinical use as patients often will receive multiple doses over time to determine 
tumor response, progression, and potentially even local metastasis. Therefore, the use of 
NIR absorbing organic nanoparticles offers a substantial improvement as nanocontrasting 
agents detectable by optoacoustic imaging.  
In this study, I synthesized, modified, and evaluated an acidic extracellular pH-
targeting polypyrrole chitosan-coated hollow nanosphere as a tumor targeting 
nanocontrasting agent detectable by multispectral optoacoustic tomography [38, 
39].  With the addition of the V7 ligand to the PPy-CS, the nanoparticle displayed 
enhanced targeting capabilities in vitro.  To the extent of my knowledge, this is the first 
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recorded tracking of a polymer-based nanoparticle through optoacoustic imaging in any 
ovarian cancer cell line, without the use of an additional contrasting agent.  This 
nanoparticle is unique in the fact that the polypyrrole-coating provides an enhanced 
spectrum of detection through its inherent absorbance in the infrared region.  The 
incorporation of this nanoparticle and fluorescent dye has proved to be a successful 
contrast agent and displays great promise for possible future use as a nanovehicle for 
chemotherapeutics.       
 2.  RESULTS AND DISCUSSION   
2.1 Particle Synthesis and Characterization  
The schematic seen in Figure 1 displays the experimental method which was used 
to synthesize the PPy-CS.  From transmission electron microscopy (TEM) analysis (Figure 
1B), we were able to confirm the successful removal of the AgCl cores as well as the 
desired relatively small-size of 43.56 ± 9 nm in diameter with a pore-size of 15 ± 6 nm  
(This size is approximately equivalent to the eye-lash of Abraham Lincoln on the penny). 
Nanoparticles with a size greater than 100 nm tend to be too large and would eventually 
be filtered out by macrophage found in the liver or kidneys [40].  Therefore, particle size 





Additionally, particle size was confirmed with the use of dynamic light scattering 
(DLS) [41].  Figure 2 displays the DLS measurement of the PPy-CS maintaining a particle 
size of 51.39 nm.  This measurement was slightly larger than the desired range of less 
than 50 nm; however, it remained consistent with the readings from the TEM images.  This 
desired size was obtained through a series of dialysis in ammonium hydroxide and 
modified measurements of the initial substrates to form the silver-chloride core.      




Zeta potential was incorporated to measure the change in voltage exhibited by the 
nanosphere [42].  Zeta potential is utilized in determining the potential difference between 
a solid surface of a particle and its conducting solvent.  This technique was used to help 
determine the expansion of the chitosan-coat in the presence of acidic pH and to ensure 
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encapsulation in the presence of more neutral pH.  The zeta potential of the nanospheres 
in various pH displayed a difference of -12.4 to -9.6 (Figure 3).  An increase in voltage was 
seen as the corresponding pH decreased [43, 44].  As pH decreased, the 
attraction/stability between the pyrrole-coating and chitosan increased and resulted in 
enhanced binding with regards to pH-specificity. These results confirmed the formation of 
the nanosphere with a functional chitosan-coat. 




The absorbance properties displayed by the PPy-CS, alone, allowed for detection 
using MSOT without the aid of a dye or any other indicator.  This inherent absorbance 
signal provides a significant advantage to the further development of tumor-targeting 
nanocontrasting agents.  To the best of our knowledge, we believe this is the first study 
that depicts the tracking ability of a polymer particle without the aid of an additional 
contrasting agent by means of optoacoustic imaging.  With the aid of the MSOT system, 
we were able to determine that the synthesized nanosphere displayed its own unique 
absorbance signal which was distinguishable from the IR-780 dye (Figure 4).  The pyrrole, 
alone, emitted a signal greater than 800 nm and extended onward, while the PPy-CS 
hollow nanospheres emitted a peak at 710 nm (Figure 5).    
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With increased ability to ascertain the biodistribution of the nanospheres and dye 
separately, we were better able to track the efficiency of the nanoparticle’s tumor-targeting 
capabilities.  The development of a nanocontrasting agent with the ability for detection, 
without the limitation of a dye, enables for enhanced detection as well as further insight in 
the trajectory and effectiveness of delivery of chemotherapeutics.  This unique property 
may prove to be a strategic indicator in future studies and possibly minimize 





2.2 Determination of pH specificity of V7-conjugated PPy-CS hollow nanospheres in vitro   
Two ovarian cancer cell lines, ES-2 and A2780, were utilized to determine cellular 
uptake of the nanoparticles.  ES-2 cell lines are an aggressive cell line and are typical in 
patients who are diagnosed with later stage ovarian cancer.  A2780 cell lines are not as 
aggressive, but are a type found in many patients diagnosed with ovarian cancer as well.  
The nanoparticle, containing IR-780 dye, was introduced to both cell lines and placed on 
a rocker in a non-CO2 incubator to allow for distribution of the particle throughout the well.  
A non-CO2 incubator was utilized in order to prevent possible changes in the pH of the 
media, if it were to interact with carbon-dioxide.  The plates were then placed on odyssey 
infrared imaging to determine uptake of the nanoparticles in the cells.    For both cell lines, 
greater uptake was observed in the more acidic environments, pH 6.6, compared to those 
in neutral, pH 7.4.  For the A2780 cell line, binding was approximately 9.3 times greater 
for the corresponding pH levels. For the ES-2 cell line, binding was approximately 7 times 
greater in pH 6.6 compared to 7.4. (Figure 6).     










Tissue-phantoms were used to further test the pH-specificity of the dye-conjugated 
PPy-CS.  Two separate conjugation processes were used to determine which displayed 
a greater level of binding, with regards to acidic pH.  (3-Aminopropyl) triethoxysilane 
(APTES) is utilized as a cross-linker, which aids in the binding of the peptide-linker, 4-(N-
Maleimidomethyl)cyclohexanecarboxylic acid N-hydroxysuccinimide ester (SMCC) to the 
surface of the nanoparticle. APTES is needed in order to fully conjugate the V7-peptide to 
the nanoparticle.  The introduction of APTES in the early conjugation process displayed 
3.5 times greater binding intensity at pH 6.6 compared to pH7.4.  This earlier addition 
occurred after the encapsulation of the dye.  The later addition occurred after the addition 
of SMCC.  However, the addition of APTES at the later stages of conjugation displayed 
9.4 times greater binding intensity for the corresponding pH (Figure 7).    This variation in 
APTES addition may display the role of the linker as a more efficient intermediary agent 










2.3 Cellular uptake of PPy-CS   
To further determine the pH specificity of the PPy-CS, fluorescence microscopy 
was performed to verify whether or not the PPy-CS were truly being anchored into the 
tumor cells [45].  Propidium iodide was utilized as the contrasting agent.  Because 
Propidium iodide is not a cell permeable dye, it was encapsulated into the nanospheres in 
order to monitor the intracellular uptake and dye release in conjunction with acidic 
pHe.  The fluorescence of red compared to green confirmed whether cellular uptake or 
accumulation on the surface was taking place.   
2.4 Dye-Release Assessment of Cargo-Carrying Capability   
PPy-CS loaded with IR-780 dye were evaluated for pH-specific dye release.  The 
dye-conjugated nanoparticles were introduced into phosphate buffer saline (PBS) 
solutions of pH 6.6, 6.9, or 7.4.  The PPy-CS in PBS solution of pH 6.6 were found to have 
released ~1.7 times greater the amount of IR-780 dye compared to those in PBS solution 
of pH 6.9 and 7.4 (Figure 8).  It was determined that the level of absorbance directly 
correlated with the amount of IR-780 dye that had been released from the PPy-CS [46]. 
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This contrast in dye release illustrates the preferential release of cargo displayed by the 
PPy-CS.  From these dye-release kinetics, it can be inferred that introduction of the 
nanospheres in vivo will result in targeted release of cargo to the tumor-region and limited 
off-targeting to non-malignant tissue.  In a clinical setting, the nanovehcles, containing the 
infrared dye, is detected with a handheld scanner and the image is then seen on the 
optoacoustic system.  This provides a less-invasive and more accessible method of 






The pyrrole-coating provided a flexible structure which allowed for the nanosphere 
to better conform to its surroundings [47].  The PPy-CS were better-equipped to adapt to 
the change from neutral pH to more acidic pH without fracturing the overall integrity of the 
structure and pre-maturely releasing its cargo.  The chitosan-coating expanded, in the 
presence of acidic pH, and released the dye.  However, in the presence of neutral pH, the 
chitosan-coating would remain intact and continue to encapsulate the dye.  This specified 
targeting and specified release helped to prevent off-targeting.  The PPy-CS, carrying dye, 
required a rate of release that was not immediate and random, but discharged at a rate in 




3. CONCLUSION  
In this study, pyrrole exhibited inherent absorbance properties which allowed it to 
be detected without the aid of a contrasting dye.  This distinction would allow for a more 
precise tracking of the targeted nanosphere in vivo.  With pyrrole serving as the principal 
encapsulating vehicle, a hollow nanosphere with a dual pH-specific mechanism was 
developed using a silver-chloride core template with pyrrole and chitosan-coating.   It was 
then conjugated with a specifically designed pH-specific reactive ligand to allow for tumor-
targeting.   Conjugated PPy-CS displayed active tumor-targeting capabilities in in vitro 
studies with limited off-targeted binding.  The use of a pyrrole-based nanoparticle 
incorporated with fluorescent dye has presented itself as a novel nanocontrasting 
agent.  The nanoparticle demonstrated a sufficient size of ≈ 44 nm with a pore size of ≈ 
15 nm.  This target size allows for efficient uptake by tumor cells without the 
disadvantageous side-effects of larger particles such as targeting by macrophage in the 
kidneys.  These dimensions are most suitable for transport and navigation towards the 
tumor cells once intravenously introduced.    
Using various imaging modalities, we further evaluated the biodistribution and 
tracking of the PPy-CS and established that the nanospheres exhibited amplified signaling 
and pH specificity.  This unique inherent absorbance displayed by the PPy-CS allowed for 
enhanced detection of the nanosphere by the imaging system. The inherent absorbance 
provided an individual spectrum which allowed for a distinction between the actual 
nanoparticle and the location of the IR-780 dye.  Being able to distinguish the location of 
the separate components allowed for a more accurate interpretation of the effectiveness 
that the nanoparticle would display in locating the desired tumor-region.            
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In future studies, the PPy-CS will be functionalized to serve as nanocarriers for 
chemotherapeutics due to its unique tracking capabilities in photoacoustic 
imaging.  Additional modifications will be made to the nanoparticle to develop it as a 
radiosensitizer to allow for enhanced treatment in radiation therapy.  The further 
elaboration of this study provides great potential toward the development of a theranostic 
agent for clinical applications.    
 
4.  EXPERIMENTAL SECTION   
Materials:  Silver Nitrate (AgNO3), Pyrrole, Chitosan, Iron (III) Chloride (FeCl3), (3-
aminopropyl) triethoxysilane (APTES), 4-(N-Maleimidomethyl)cyclohexanecarboxylic acid 
N-hydroxysuccinimide ester (SMCC)( ≥98%, powder), Dialysis Tubing benzoylated, 
Ammonium Hydroxide (NH4OH), Nitric Acid (HNO3) were purchased from (Sigma-Aldrich, 
St. Louis, MO) and used as received. Dulbecco’s Modified Eagle’s Medium (DMEM), L-
glutamine, and RPMI medium were purchased from Life Technologies (Grand Island, NY). 
Fetal bovine serum (Atlanta Biologicals, Lawrenceville, GA) and the V7 ligand (Cisbio, 
Bedford, MA) were used as received.   
Characterizations:  The UV-vis absorption spectra were recorded with both MSOT and a 
Thermo-Scientific Model NanoDrop 2000 spectrophotometer. TEM images were obtained 
using a Tecnai-F20.  Each TEM sample was prepared by dropping 50 µL of nanoparticle 
solution (in Milli-Q) on to copper-mesh grids (Electron Microscopy Science, Hatfield, PA) 
and they were then allowed to dry in room temperature overnight before imaging.  For 
zeta-potential, the samples were measured by a Zetasizer Nano-ZS (Malvern Instruments 
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Ltd.) at room temperature.  Smoluchowski’s equation was used to determine the 
electrophoretic mobility (µE) of the sample:   
 
The ζ stands for the zeta-potential, ε the existing permittivity of the solvent, and η the 
viscosity of solvent. The same Zetasizer Nano-ZS (Malvern Instruments Ltd.) was used to 
measure size distribution for Dynamic Light Scattering (DLS).  
Preparation of Materials:  Stir bars, spatulas, and beakers were cleaned and thoroughly 
rinsed with DI water and Ethanol, and were then placed in autoclave.  Materials were 
allowed to cool before any reactants were added.      
Synthesis of AgCl Core Solution:  The additions and polymerizations of this preparation 
step occurred in a 5° C environment. 0.003g of AgNO3 and 0.0083 mL of pyrrole were 
added to a 6.7 mL chitosan solution (1% weight in 0.05 M HNO3).  0.047g of FeCl3 was 
dissolved in 5 mL of Milli-Q water and the dispersion was then introduced to the chitosan 
solution.  The resulting solution was polymerized for 12hrs.  Once polymerization was 
completed, dialysis tubing was utilized to remove impurities from the mixture.  Dialysis 
tubing was placed in a 0.05 M HNO3 solution for an additional 12 hrs.  Lastly, the AgCl 
core-shell material was obtained by a series of precipitation with acetone and 
centrifugation (4000 RPM for 25 min).  Once the supernatant was removed, the precipitate 
was placed in a vacuum for 12 hrs at room temperature.  The resulting product formed 
was the AgCl core-shell material.  
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Synthesis of PPy Hollow Nanosphere:  A 0.005g portion of the AgCl core-shell material 
was dispersed in 20 mL of Milli-Q water by a combination of vortex and 
ultrasonication.  The pH of the solution was adjusted to 12 by drop-wise addition of 5M 
NH4OH and then stirred for 24 hrs in a 5° C environment.  Dialysis tubing was used to 
remove the formed silver ammonia ions.  This removal process occurred in a 0.1M NH4OH 
solution.  Once dialysis was completed, the pH of the solution was adjusted down to 4 with 
the drop-wise addition of 2M HNO3.  Finally, the PPy hollow nanospheres were obtained 
by a series of precipitation with acetone and centrifugation (4000 RPM for 30 min).  Once 
the supernatant was removed, the precipitate was placed in a vacuum for 12 hrs at room 
temperature.  The resulting product formed was the PPy hollow nanospheres.   
Conjugation of V7-Ligand to PPy-CS Hollow Nanosphere:  0.0025 g of the solid PPy-CS 
material was obtained and placed in an Eppendorf tube containing 1 mL of phosphate 
buffer solution (PBS) containing a pH of 7.4.  This solution was then dispersed by a series 
of vortex and ultrasonication.  From the solution, 300 µL were placed in a separate 
Eppendorf tube and 30 µL of APTES were added and the mixture was vortexed for 30 
min.  Once finished, the pH of the solution was reduced down to 3.8 and 30 µL of IR-780 
dye was introduced.  The solution was then vortexed for 20 min.  After this second round 
of vortex, the pH of the solution was readjusted back up to 7.4 with the drop-wise addition 
of NaOH and this resulting mixture was placed on vortex for 10 min.  Next, 50 µL of SMCC 
(15 mM, 0.005014g in 1mL of DMF) was introduced to the solution and immediately after 
50 µ of the V7-ligand (0.005g in 300 µL of DMF) was added as well.  The Eppendorf was 
then vortexed for 12 hrs.  
Cell Culture:  The ovarian cell lines A2780 and ES-2 were cultured in DMEM medium (Life 
Technologies) with 10% FBS (Atlanta Biologicals) and 1% L-Glutamine (Life 
Technologies) at 37° C in a humidified atmosphere of 5% CO2.   
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 In Vitro Infrared Imaging to Determine pH-specificity:  A2780 and ES-2 cells were placed 
in 6-well plates at a density of 500,000 cells per well.  The 2 separate rows contained 
varying pH- media.  One contained a pH of 6.6, whereas the other maintained a pH of 
7.4.    After 24 hrs of incubation at 37° C and non-CO2, 50 µL of V7-conjugated PPy-CS 
hollow nanosphere (22.85 µM) was introduced to two of the columns for the A2780 and 
the ES-2 cells.  The last column served as a control group.  The cell-plates were placed 
on a rocker in the non-CO2 incubator for 20 min; it was then placed on the Odyssey (LI-
COR Biosciences) to determine if there was signaling present.  Once signaling was 
detected, the cell-plates were washed with the corresponding phosphate buffer solution 
(PBS) and then placed back in to non-CO2 incubator for an additional 20 min.  The need 
for placement in a non-CO2 environment stemmed from the desire to prevent side-
reactions between the pH-specified phosphate buffer and the environmental carbon-
dioxide. This process was repeated 3 times until optimal pH-specific signaling was 
achieved.  Dosimetry analysis of IR-780 dye was conducted using Image-J software.      
Optoacoustic Imaging of Tissue Phantoms:  Tissue Phantoms (A mixture of agar and lipid 
used to mimic living tissue) provide an ideal model in allowing for comparable density and 
size found in mice.  This model of imaging allows for an indicator of possible success in 
vivo.  ES-2 cells were placed into 6-well plates for 24 hrs in DMEM media.  After 
completion, the media were removed, pH-specific media were then applied and the cells 
were incubated for 4 hrs at 37°C in non-CO2.  The PPy-CS hollow nanospheres (50 µL) 
were then added to the wells and rocked in the incubator for an additional 2 hrs.  Next, the 
cells underwent a series of 3 washes with specified PBS of pH 6.6 and 7.4 to each row. 
The cells were then scraped from each well and were collected in 1 mL of the 
corresponding PBS.  Tissue phantoms were constructed with the use of Agar (Sigma 
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Figure 1:  A.)  The silver-core portrayed by the silver circle is enclosed by a chitosan-coat 
depicted with the porous blue sphere.  At pH of 6.6, V7 ligand became active and 
dye release was present.  The protruding red-lines represent the active V7 ligand 
and the smaller circles depict cargo-release.   At pH of 7.4, dye release was much 
less significant.  B.)  Transmission Electron Microscopy (TEM) images 
demonstrate the successful removal of the AgCl core to form the PPy-CS hollow 
nanospheres. The TEM images display the diameter of the PPy-CS hollow 
nanospheres as 43.56 + 9 nm with a pore size of 15 + 6 nm 
Figure 2:  Dynamic Light Scattering (DLS) measurement of PPy-CS hollow nanospheres 
demonstrate a size of 51.39 nm.  This size is within the range depicted from the 
TEM imaging. 
Figure 3: The conjugation of PPy-CS hollow nanospheres with chitosan.  Zeta Potential 
confirms the presence of chitosan on the nanoparticle.  This can be seen with the 
increase in pH with the corresponding decrease in voltage.  This correlation is the 
result of lessened protonation on the chitosan coated PPy-CS hollow nanospheres 
Figure 4:  Multispectral optoacoustic tomographic (MSOT) image of the conjugated PPy-
CS hollow nanosphere in phantom tissue displays distinct absorbance spectrum 
detected by MSOT system. 
Figure 5:  The absorbance spectrum for the PPy-CS hollow nanosphere was obtained.  
From phantom imaging, the pyrrole present in the particle exhibited a signal on its 
own without the aid of IR-780 dye. 
Figure 6:  A.) Odyssey Infrared Imaging displays distinct in-vitro cellular uptake in acidic 
cellular environment, pH 6.6, compared to that of pH7.4.  B.) Odyssey images 
display a significant difference in the level of intensity of signal that was present 
between the PPy-CS hollow nanospheres in pH of 7.4 compared to that of pH 6.6.   
Figure 7:  During tissue phantom imaging, two samples were used to determine which 
procedure, for the addition of APTES, provided the greatest difference in signal 
between pH of 7.4 and 6.6.  Both particle samples resulted in a difference in the 
signal intensity. However, the addition of APTES before the conjugation of SMCC 
and V7 displayed a greater difference in signal intensity compared to the addition 
of APTES along with the initial PPy-CS hollow nanospheres.  APTES (First) 
displayed a difference of approximately 7 times more intensity for pH 6.6 compared 
to 7.4.  APTES (Later) displayed a difference of approximately 9.4 times more 
intensity for pH 6.6 compared to 7.4. 
Figure 8:  PPy-CS hollow nanospheres loaded with IR-780 dye were evaluated for pH-
specific dye release.  The dye-conjugated nanoparticles were introduced into 
phosphate buffer saline (PBS) solutions of pH 6.6, 6.9, or 7.4.  The absorbance 
level of each solution was measured by UV-Vis spectroscopy over a 10 hour period.  
It was determined that the level of absorbance directly correlated with the amount 
of IR-780 dye that had been released from the PPy-CS hollow nanospheres.   The 
PPy-CS hollow nanospheres in PBS solution of pH 6.6 were found to have 
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released ~1.7 times greater the amount of IR-780 dye compared to those in PBS 
solution of pH 6.9 and 7.4.  This contrast in dye release illustrates the effective pH-
specificity found in the PPy-CS hollow nanospheres. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
